General MedicationsINTRAVENOUSGeneric
ZOLEDRONIC ACID
ZOLEDRONIC ACID
Standard Dose
EQ 4MG BASE/100ML (EQ 0.04MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview ZOLEDRONIC ACID is listed in Drugs@FDA under application 204016 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient ZOLEDRONIC ACID Form and strength SOLUTION;INTRAVENOUS - EQ 4MG BASE/100ML (EQ 0.04MG BASE/ML) Sponsor HOSPIRA Submission history Latest submission status date: 2018-12-19 00:00:00.
Structured Monograph
Clinical summary
Approval overview ZOLEDRONIC ACID is listed in Drugs@FDA under application 204016 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ZOLEDRONIC ACID Form and strength SOLUTION;INTRAVENOUS - EQ 4MG BASE/100ML (EQ 0.04MG BASE/ML) Sponsor HOSPIRA Submission history Latest submission status date: 2018-12-19 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.